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Abstract: The primary objective of the study was to explore the effectiveness of Vertebral Axial Decompression (VAX-D) in 
treating patients with chronic low back pain (CLBP) as a safe and competent therapeutic method. Also, to determine the 
quality of life in alleviating chronic lumbar pain using mechanical Lumbar traction force applied to the lumbar spine. A 
systematic review and meta-analysis involving detailed literature survey on Vertebral Axial Decompression (VAX-D) therapy 
for patients with chronic low back pain were conducted in three databases namely MEDLINE, EMBASE and Cochrane 
Library from (January 1994 to February 2019). Studies supporting the outcomes with qualitative statistical analysis on chronic 
low back pain and Lumbar traction were retrieved. We retrieved sixteen randomized controlled trials (RCTs) for systematic 
review, and 6 studies were found to be eligible for inclusion in meta-analysis with a sample size of 486 patients receiving 
Lumbar traction. Among them, one study was found to be high quality that detailed the positive relationship between reduction 
of pain intensity after VAX-D therapy. However, most of the studies are unsuccessful in demonstrating an improvement 
towards the patient's mobility or quality of life. There is no reliable indication of the efficacy of VAX-D therapy for chronic 
low back pain patients. Studies on VAX-D had methodological errors and inadequate data for profound statistical analysis. 
Further, there was no evidence to show the dosage requirement, patient position, and settings on the VAX-D table that led to 
observed outcomes. Any prospect of research focusing on LBP morbidity should enable to distinguish between symptom 
duration and pattern with accurate standard methods. Therefore, more studies validating the effective treatment strategies in the 
management of patients with chronic low back pain are warranted. 
Keywords: Vertebral Axial Decompression, Chronic Low Back Pain, Lumbar Traction, Lumbar Spine, Quality of Life, 
Randomized Controlled Trials 
 
1. Introduction 
Chronic low back (CLBP) exists as one of the significant 
causes of disability worldwide. CLBP is a well-recognized 
public health burden, and treatment cost has peaked 
progressively during four decades. Although there is an 
increasing prevalence of CLBP [1], however, their effective 
treatment modalities remain elusive. CLBP is experienced by 
the illnesses affecting the bony lumbar spine, ligaments 
around the backbone and discs, intervertebral discs (discs 
between the vertebrae), spinal cord and nerves, muscles of 
the low back, internal organs, and the skin covering the 
lumbar area. The early LBP is a symptom, not a disease, and 
it has a wide range of causes. Chronic LBP was prevalent and 
was found to be approximately 84%. In most of the cases, 
they are mild to moderate and tentative to repeat without 
affecting the daily activities, and thus, the majority of the 
individuals with LBP do not seek medical care. In the United 
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States, 10-15% of acute LBP becomes chronic; 1% can pro-
gresses to permanent disability consuming up to 90% of 
health care and social costs for treatment of low back pain 
[2]. Despite the acceptance of low back pain disability and 
provision of disability benefits for sufferers in society have 
significantly contributed to the growing trend of LBP 
disability. 
CLBP was identified as the third most common cause for 
physician visits in males and sixth in females accounting for 
6% of all physician visits. One in every three physiotherapist 
consultations, 2.5% of drug prescriptions, and 5-10% of 
imaging studies were for CLBP [3]. A report from the USA 
denoted that approximately 1 in 4 adults face the burden of 
low back pain that lasted at least 24 hours within the previous 
3 months and about 8% of individuals experience at least one 
incidence of severe acute LBP within a year period [4, 5]. 
Studies conducted on CLBP, reports that around 13% of 
work-related injuries result in LBP disability in younger 
individuals (< 45 years) and the common leading cause for 
sick leaves. 
Also, low back pain is the primary cause of inactivity and 
unsatisfactory work progress resulting in a vast economic 
burden on individuals; families, communities, industry, and 
governments’ worldwide [6-9]. In 1998, overall health care 
incremental costs were assessed to be $26.2 billion that is 
directly attributed to LBP in United States [10]. 
Lumbar traction is an effective conservative method used 
in the treatment of lumbar disc herniation. It is routinely done 
by self or in combination with other therapies for the 
management of lumbar sciatica [11, 12]. A better relief to 
vertebrae separation has been shown by traction technique, 
which could provide radicular symptoms relief by directly 
removing pressure or forces of contact from affected neural 
tissue. It may also have particular benefits by stretching soft 
tissues [13]. 
The mechanisms of action of LT are mediated by 
mechanical force through a separation of intervertebral 
motion segments [14-16] leading to a substantial decrease in 
intradiscal pressure [17-19], and neurophysiological, through 
the modulation of the pain pathways by equivalence with 
spinal manipulations [20]. Vertebral Axial Decompression 
(VAX-D) technique uses significant distractive forces to the 
lumbar spine in a graduated, progressive manner using 
electric components and an advanced computer control 
system [21]. 
An alternative or additional treatment for secondary 
radicular lumbosacral pain to herniation disc is traction. A 
motor pulley was designed to provide a segmental 
mechanized distraction that resources this sort of nonsurgical 
decompression in the spinal region which can be delivered 
either in an oscillatory or static fashion for a fixed period. 
The elimination of frictional resistance by split table design 
between table and patient, and provides manageable, 
effective decompression to the spinal region and a noticeable 
reduction in intradiscal pressure [21]. 
Approximately after one month of treatment, only patients 
who received VAX-D sessions every alternate day had a 
47.4% progress in their pain intensity; with improvements 
functionally by 17.7%. After three months, it is further 
reduced by 79.4% of their pain intensity, and their 
improvements in functional were found to be 50.8%. 
However, the proportion of the increase in function and pain 
was significantly different in various cases.  
A distinct retrospective study also showed benefit with 
motorized spinal decompression over standard pelvic 
traction [22]. Beattie et al. conducted an 8-week course of 
VAX-D and observed significant outcome improvements 
for all the post-intervention scores when compared with the 
pre-intervention score [23]. Despite these projected 
neurologic or/and mechanical mechanisms of action, 
currently, there is no clear consensus regarding the amount 
of force to apply in LT interventions. In this connection, 
popular retrospect articles report mainly that evidence that 
is limited or conflicting to support the valuable effect of 
Lumbar Traction versus sham or no treatment in patients 
with lumbar sciatica [24, 25]. Thus, the outcomes found 
from the studies are somewhat problematic to interpret, 
given the heterogeneity of levels, modalities, durations of 
tractions, treatment duration, and medical status of patients 
[26-28]. 
Cholewicki et al. have reported that antagonistic trunk 
muscle co-activation is necessary to provide mechanical 
stability to the lumbar spine around a neutral posture that 
results in an improved response to increasing the axial load 
on the needle [29]. Thus, agonist-antagonist muscle co-
activation resulting from vibration therapy might have 
improved the patient's motor control strategy to enhance joint 
stability and movement accuracy. 
Further, traction therapy along with spinal decompression, 
can functionally enhance the extension strength in lumbar 
and in both dynamic and static balance which are required to 
endure a spinal position neutrally. Both vibration and traction 
therapy has been associated with reducing pain intensity in 
patients with LBP. Recently, Wang et al [30] stated that 
traction applied to patients while lying on a table in 
combination with 12Hz of vibration was significant in 
decreasing muscle fatigue of the lumbar erector spinae. 
Six studies were analyzed in groups determined by 
similarity of patients, interventions, comparisons, and 
outcomes to perform the meta-analysis. This study critically 
evaluates data from randomized controlled trials (RCTs) 
using VAX-D technique for people with CLBP. The 
primary goal of this study is to compile a substantial 
amount of peer-reviewed journal articles and provide an 
unbiased and non-conflicting perspective on the efficacy of 
the VAX-D system. 
2. Materials and Methods 
An extensive search of scientific articles in reputable peer-
reviewed journals was done to compile approximately 50 
articles. The series of literature searches from January 1994 
to February 2019 included using search engines PubMed, 
EBSCO multi-search, and Google Scholar electronic 
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databases. Keywords used included vertebral axial 
decompression, efficacy, lumbar traction, VAX-D, low back 
pain, and therapy. Keywords were combined and used to 
collect related data. First, abstracts were screened, and if an 
item satisfied our inclusion criteria, it was retrieved for full 
article use. Additional materials were also extracted by 
searching cited references for related content. Manual 
searches of insurance company policies regarding VAX-D 
coverage were also included. The search was limited to only 
published papers in the English language. 
2.1. Study Selection 
The articles that met our inclusion criteria were prepared 
for analysis using Purdue Owl as consultation for writing, as 
well as insight into critically dissecting journal articles. To 
compare and compile the necessary information for our 
systematic review, we examined the following qualities of 
each item: blinding of subjects, the method of subject 
selection, experimental outcomes, comparison of 
experimental and control groups, and avoidance of bias. A 
manual search for additional references was also performed. 
Therefore, there could be some publication and language bias 
in the review. Initially, we screened 50 abstracts, but only 23 
articles were found to fit our inclusion criteria as outlined in 
Table 1. Seven of 23 were disqualified for a variety of 
reasons, including: a single case report (n=1), a retrospective 
survey (n=1), studies using a machine other than VAX-D 
(n=2), an article that was not peer-reviewed (n=1), an opinion 
paper (n=1), and a study with no methodology (n=1). 
Therefore, we retrieved 16 relevant articles for our literature 
analysis. Figure 1 shows the stages of study selection and the 
number of studies at each step. 
Inclusion criteria contained scientific journal articles 
and writings that identified vital elements about the aims 
of this systematic review. Participants included in the 
analysis were over the age of 18 and had the clinical 
diagnosis by a licensed physician and confirmed by 
diagnostic imaging of chronic low back pain with or 
without radiculopathy or sciatica, herniated disc, 
degenerative disc disorder, or facet injury. The study also 
had to use at least one of four primary outcomes: pain, 
disability index questionnaire, quality of life, and an 
overall measurement of improvement. 
 
Figure 1. Flow chart of study selection. 
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Exclusion criteria consisted of articles published before 
1994 and in languages other than English. Studies that 
admitted conflict of interest with the VAX-D company or 
involved motorized cervical traction and other methods of 
vertebral decompression that were mechanically controlled. 
If a study included patients with surgical hardware of the 
spine, the use of materials produced by a manufacturer other 
than VAX-D, LBP caused by specific pathological origin 
(infection, osteoporosis, etc.), or was an isolated case study 
were excluded. 
Table 1. Characteristics of Selected Studies. 
Author and year Clinical Dx Course of Tx Additional therapies used with VAX-D 
Beattie et al 2007 
[23] 
Diagnostic imaging evidence of a 
degenerative and/or herniated 
intervertebral disk. 
Patients had an eight-week course of prone VAX-
D treatment consisting of five 30-minute 
sessions/week for four weeks, followed by one 
30-minute session/week for four additional 
weeks. 
N/A 
Naguszewski et al 
2001 [31] 
Clinical diagnosis of LBP and 
unilateral or bilateral L5 or S1 
radiculopathy confirmed by CT 
or MRI. 
Treatment sessions varied from 10 to 35 minutes. 
Bilateral lower extremity dermatomal 
somatosensory evoked potentials 
(DSSEPs). 
Ramos 2004 [21] 
Chronic LBP with or without leg 
pain, confirmed by MRI or CT 
scan. 
15 distraction and relaxation cycles per day five 
days/week for either two or four weeks. 
Medication allowed as needed. All other 
treatment was stopped. 
Ramos 2004 [21] 
Disc herniation at one or more 
levels confirmed by MRI. 
Measuring intradiscal pressure by inserting the 
cannula into the nucleus pulposus of the disc 
Not indicated. 
Sherry et al 2001 
[32] 
Chronic LBP, associated leg pain, 
and Confirmed disc protrusion or 
herniation on CT or MRI. 
30-minute treatment session, 15 cycles of 
decompression/relaxation, 5 days/week for 4 
weeks. 
Non-narcotic pain relievers, no PT, 
injections or any other treatments allowed. 
Tilaro et al. 1999 
[33] 
17 patients with radiculopathy 
and abnormal sensory function. 
Present Perception Threshold evaluations on 22 
nerves of peripheral were taken after and before 
VAX-D. 
Unknown 
Beattie et al 2007 
[23] 
Diagnostic imaging evidence of a 
degenerative and/or herniated 
intervertebral disk. 
Patients had an eight-week course of prone VAX-
D treatment consisting of five 30-minute 
sessions/week for four weeks, followed by one 
30-minute session/week for four additional 
weeks. 
N/A 
Naguszewski et al 
2001 [31] 
Clinical diagnosis of LBP and 
unilateral or bilateral L5 or S1 
radiculopathy confirmed by CT 
or MRI. 
Treatment sessions varied from 10 to 35 minutes. 
Bilateral lower extremity dermatomal 
somatosensory evoked potentials 
(DSSEPs). 
Table 1. Continued. 
Author and year Results Limitations Conclusions 
Beattie et al 2007 
[23] 
250/296 patients (84.4%) completed treatment. 
Of the subjects that completed the full 24 
visits, 247 patients (83.4%) followed up at 30 
days and 241 (81.5%) at 180 days. 
This was a prospective, longitudinal 
case series study, not a randomized 
control trial. Due to weather constraints, 
not all the subjects attended all 24 
therapy sessions. They did not observe 
spinal nerve compression. 
Treatment with VAX-D for eight 
weeks showed a decrease in pain 
intensity (RMDQ) at discharge and 
at the 30- and 180-day follow-up 
period. 
Naguszewski et al 
2001 [31] 
The average pain reduction was 77%. All 
patients had at least 50% improvement in LBP 
and radicular symptoms. Complete resolution 
of symptoms was observed in 3 patients. 
Small sample size. Unsure if positive 
results are due to a placebo effect. No 
long-term effects. 
17/28 nerve root responses showed 
improvement after VAX-D therapy. 
Ramos 2004 [21] 
Patients receiving the 20 sessions had a 
statistically significant remission of pain 
compared to the 10-session group. 
Does not address efficacy, only dose-
response. Patients not randomized; 
controls were minimal. 
VAX-D achieves best results when 
used for 20 daily sessions 5 days 
per week. 
Ramos 2004 [21] 
VAX-D reduced intradiscal pressure 
significantly. Decompression shows an inverse 
relationship to tension applied. 
Small patient size. Difficult to a base 
physiological effect. 
It is likely to reduce pressure in the 
pulpous nucleus of lumbar herniated 
discs to levels below 0 mmHg. 
Sherry et al 2001 
[32] 
At 6-month follow-up, 70% of VAX-D group 
showed a sustained success. 
Small sample size, lack of blinding. 
Possible nocebo effect. 
VAX-D can achieve statistically 
significant improvement in pain and 
functional outcome. 
Tilaro et al. 1999 
[33] 
14/22 that is (64%) of nerves obtained to 
regular function, (27%) that is 6/22 enhanced, 
with no improvement towards (4.5%) that is 
1/22 and (4.5%) that is 1/22 was worse. 
Patient pain outcomes not measured. 
VAX-D is proficient of influencing 
dysfunction associated with nerve 
sensory with compressive 
radiculopathy. 
Beattie et al 2007 
[23] 
250/296 patients (84.4%) completed treatment. 
Of the subjects that completed the full 24 
This was a prospective, longitudinal 
case series study, not a randomized 
Treatment with VAX-D for eight 
weeks showed a decrease in pain 
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Author and year Results Limitations Conclusions 
visits, 247 patients (83.4%) followed up at 30 
days and 241 (81.5%) at 180 days. 
control trial. Due to weather constraints, 
not all the subjects attended all 24 
therapy sessions. They did not observe 
spinal nerve compression. 
intensity (RMDQ) at discharge and 
at the 30- and 180-day follow-up 
period. 
Naguszewski et al 
2001 [31] 
The average pain reduction was 77%. All 
patients had at least 50% improvement in LBP 
and radicular symptoms. Complete resolution 
of symptoms was observed in 3 patients. 
Small sample size. Unsure if positive 
results are due to a placebo effect. No 
long-term effects. 
17/28 nerve root responses showed 
improvement after VAX-D therapy. 
Abbreviations: N/A, not available; Tx, Treatment; Dx, Diagnosis. Only articles that were primary research articles were included. Systematic reviews did not 
appear in this table. 
2.2. Meta-Analysis 
Meta-analysis was performed in Review Manager 
(RevMan) [Computer program] Version 5.3 using the user-
contributed commands forest plot and funnel plot. 
Standardized mean differences (SMDs) and subsequent 
Odd’s ratio (OR) were calculated for studies that are included 
using standard deviations, means, and sample sizes reported 
in the relevant publications. A negative SMD relates to a 
score with lower back pain being associated with the group. 
2.3. Post Hoc Sensitivity Analysis 
Effective evaluations were pooled using random model 
effects. Unlike fixed model effects, which assume that every 
study evaluates the same size effect, a random model effect 
considers that every study evaluates a diverse effect. The data 
presented in our study were drawn from a particular common 
distribution. Additionally, random sampling error, variances 
could also be due to differences between study designs and 
populations. The I2 statistic was also considered, which 
evaluates inconsistency between proximity and is 
independent of the size sample. 
The inclusion depends on only the studies reporting results 
at initial follow-up and the last follow-up time points as a 
comparison in the primary analysis. However, to maximize 
the comparability, the studies included were used to test the 
intensity of pain measured after VAX-D treatment (between 
reduced pain Vs. increased pain). One sensitivity analysis 
included only studies which collected pain measurements 
immediately post-treatment. While other sensitivity analyses 
as being at a high RoB were considered with the effect of 
included studies. 
3. Results 
The search strategy initially identified 50 studies, 27 of 
which were excluded when limits were applied (clinical trials 
with humans, full-text English or Spanish language, and 
exceeds selected years). The residual 23 articles were 
reviewed; of these, 14 were excluded for being duplicated. 
Seven of 23 were disqualified for a variety of reasons, 
including: a single case report (n=1), a retrospective survey 
(n=1), studies using a machine other than VAX-D (n=2), an 
article that was not peer-reviewed (n=1), an opinion paper 
(n=1), and a study with no methodology (n=1). Therefore, 16 
relevant articles were used in our literature analysis. Finally, 
16 articles were found to satisfactory and had an adequate 
methodological quality and were consequently selected for 
the review and analysis of their results and conclusions. The 
procedure of the investigation is summarized in Figure 1. 
3.1. Risk of Bias 
All the trials contained in our study were randomized-
controlled parallel studies. The method of randomization was 
reported in five trials [21, 23, 32, 33]. Beattie et al [23] study 
determined short- and long-term outcomes by using the 
VAX-D protocol after administration of prone traction. The 
method was applied to a sample of patients with activity-
limiting LBP that had been refractory to at least two sessions 
of previous, non-operative interventions, with a lack of 
randomized clinical trials. 
Naguszewski et al [31] study used dermatomal 
somatosensory suggested potentials (DSSEPs) to determine 
lumbar root decompression following VAX-D therapy. The 
selected subjects are DSSEPs satisfied patients undergoing 
lumbar spine surgery and the randomized trial was not sensed 
in this study. However, the intervention and other follow-ups 
were suitable for this analysis. The Ramos [21] study 
compared the effects of two dosage regimens of VAX-D 
treatments (low and high) on the analogue scale for low back 
pain in patients. The study was a prospective randomized 
control trial conducted on CLBP patients advised to seek 
neurosurgical care after failing standard medical therapy. 
Sherry et al [32] conducted a randomized controlled trial that 
made attempts to address the question of appropriateness and 
efficacy of vertebral axial decompression (VAX-D) therapy. 
Tilaro [33] study proposed to determine whether VAX-D 
therapy could externally decompress the nerve root, with a 
randomized controlled trial between surgically and 
conservatively treated patients. 
All the five studies included in the analysis reported the 
time of follow-up; three studies have eight weeks course of 
lumbar traction [23, 31, 33] one reported for 4-6 weeks [32], 
and other study reported 6-12 weeks [21] For each included 
study, the outcomes listed in the methods section were all 
reported. Notable publication bias can be observed since 
most of the included and excluded studies were published in 
English or Chinese, although we have attempted to do our 
best to search all probable literature without any language 
restrictions and have contacted investigators to get more 
information. The studies included used different range of cut-
off times to a particular intensity of pain although it was 
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clearly stated that pain was persisting, or recurring, at the site 
of shingles at least. We have not restricted to include the 
studies using the same definition in order not to introduce 
more missing data. One (Sherry et al [32]) of the trials were 
rated as at low risk of bias, one (Naguszewski et al [31]) as 
high risk of bias, and another two (Ramos [21]; Tilaro [33]) 
has an unclear risk of bias (Figure 2). 
3.2. Results from the Pain Outcome Measures (Reduced 
Pain Vs. Increased Pain) 
Sherry et al [32] study, a high-quality RCT involving 
traction was found to have statistically significant differences 
on measures of pain, overall improvement with the duration 
of follow-up ranging from 1 to 8 weeks. Duration of LBP in 
patients was observed for 6 months (chronic) in Beattie et al 
[23], for >3 months (sub-acute and chronic) in Sherry et al 
[32] studies. Six studies have been analyzed to determine the 
pain outcome measures after VAX-D treatment. Five studies 
reported the outcome of post-treatment improvement with 
standard mean groups showing lower levels of pain during 
follow-up. One of the reviews of Ramos [21] reporting low 
dosage group showed improvement in pain relief and found 
to be reduced when compared to the high dosage group. 
The analysis of Beattie et al [23] showed significant 
improvements for all post-intervention outcome scores when 
compared with pre-intervention scores (p<0.01). In 
Naguszewski et al [31] study, the overall measure of pain 
from seven patients displayed significant improvement in 
post-treatment after VAX-D therapy for six studies and the 
random-effects model was 2.22 (95% CI, 0.69 to 7.13), 
corresponding to a reduction in pain among participants at 
follow-up (Figure 3). Analysis of I2 statics suggests 
inadequate evidence against the assumption of homogeneity 
between effect estimates (I2=91%, p=0.18). 
 
 
Comparison of groups underwent VAX-D therapy to determine pain intensity. 
Figure 2. Analysis 1: Forest plot. 
 
Comparison of groups underwent VAX-D therapy to determine pain intensity. 
Figure 3. Analysis 2.1 Funnel plot. 
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3.3. Pain Intensity Measurement Immediately After VAX-D 
Treatment 
The three trials, Sherry et al [32]; Tilaro [33] and Beattie et 
al [23] involved traction. Beattie et al [23] trial involving 
VAX-D suggested a favorable association between the prone 
friction applied and VAX-D from the preliminary outcome 
measures used in this study (Figure 4). However, the study is 
deficient of a randomized control group, and thereby, it is not 
possible to establish a relationship between the traction 
applied with VAX-D and outcome. In Sherry et al [32] study, 
all the VAX-D group patients were recorded with some 
improvement in their pain levels, seven (70%) have shown 
sustained success (i.e., they still meet the criteria for the 
successful outcome). 
From Tilaro [33] study, the overall improvement was 67% 
that is statistically significant (p<0.05) since the study 
evaluated VAX-D therapy outcome with regards to CPT 
score of normal nerve functioning. According to the study, 
Sixty-four percent (64%) of the patients achieved complete 
recovery of neurologic function, and it was found that risk 
ratio of 0.04 (95% CI, 0.00 to 0.58) significantly greater than 
the previously reported study. The overall pain intensity 
measurement immediately after VAX-D treatment from the 
three studies showed significant improvement from lower 
back pain with I2 statistic=0%, P=0.51, and the test for 
overall effect Z=4.22 (Figure 5). 
 
 
Comparison of groups’ pain intensity with pain measurement immediately after VAX-D treatment. 
Figure 4. Analysis 2: Forest plot. 
 
Comparison of groups’ pain intensity with pain measurement immediately after VAX-D treatment. 
Figure 5. Analysis 2: Funnel plot. 
3.4. Pain Intensity Measurement During Follow-up After 
VAX-D Treatment 
All the five trials Sherry et al [32]; Naguszewski et al 
[31]; Ramos [21] (Low dosage); Ramos [21] (High dosage); 
Beattie et al [23] involved traction with a follow-up for pain 
intensity measurement. From Naguszewski et al [31] study, 
the majority of the patients recovered from lower back pain 
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after 10-20 VAX-D sessions or therapy, and the analysis 
showed randomized risk ratio of 0.17 (95% 0.03 to 1.05). In 
Ramos [21] study, one set of patients obtained an average 
course of treatment consisting of 18 regular sessions, and 
another group obtained half the number of daily treatment 
sessions. The treatment parameters for all the patients 
differed only in terms of the number of sessions while the 
outcome differed for two groups and found that 67% of the 
higher dosage group attained remission of low back pain 
compared to 43% of the lower dosage group. The overall 
static I2 was found to be 92% with an odd’s ratio of 0.56 




Comparison of groups’ pain intensity with pain measurement during follow-up after VAX-D treatment. 
Figure 6. Analysis 3: Forest Plot. 
 
Comparison of groups’ pain intensity with pain measurement during follow-up after VAX-D treatment. 
Figure 7. Analysis 3: Funnel plot. 
3.5. Adverse Events 
None of the studies reported about adverse events. 
4. Discussion 
In our review, we have determined to use qualitative 
analysis since many studies failed to provide sufficient data 
for statistical pooling. It impacts to have false-positive 
findings with several methodological weaknesses. From this 
analysis, we observed some conflicting results regarding the 
effectiveness of VAX-D traction treatment in patients with 
lower back pain. Our main findings of the study suggest that 
VAX-D traction for LBP in patients has provided 
improvement or quality of relief after several sessions of 
treatment. Beattie et al [23] study was unable to demonstrate 
the pattern of pain among patients involved in litigation or 
those receiving compression could be managed using VAX-
D. The researchers duly noted this generalized limitation. 
Clinicians administered the sessions as per the VAX-D 
protocol and no risk of intervention bias. The type of audit 
conducted was not disclosed, and therefore, there could be 
some loss to follow-up bias. 
In Ramos [21] study, there was no randomization in the 
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assignment of participants and activities of daily living were 
assessed. Also, no data was available on any loss of patients 
to follow up, and it is difficult to assess the possibility of loss 
to follow-up bias. The study was more concerned with 
understanding the mechanism of therapeutic action as 
opposed to demonstrating the efficacy and safety of VAX-D 
in treating low back pain. 
Sherry et al [32] study reported positive outcomes of post-
treatment between VAX-D traction and TENS group of 
patients. The study has randomization and blinding to 
minimize bias, but the researchers have noted some difficulty 
in blinding since the placebo had some effects. The study had 
excluded only four patients from the original sample and 
observed the minimal possibility of loss to follow-up bias. 
This overview described the VAX-D therapy machine and 
how it was used, and a comparison between VAX-D and 
traction was made. The overview noted the absence of data 
on the effectiveness of conventional traction in reducing 
intradiscal pressure. 
Tilaro [33] study, a non-randomized retrospective 
analysis recorded the patient data. The researchers have 
appealed that patients have achieved some pain relief 
without any data, and there was no supporting evidence to 
state a conclusion on the efficacy of VAX-D in back pain 
relief. Thus, the report concluded the effectiveness of 
VAX-D in disc decompression. In this review, we lack 
robust and consistent evidence regarding the use of 
traction due to the lack of high-quality studies, the 
heterogeneity of study populations, and lack of power. 
Some other studies included hospitalized patients with 
demonstrated herniated discs, neurological findings, and 
back pain. Also, some seemed to have had sample sizes 
that were too small to detect a clinically significant 
difference. The literature review conveys firmly negative 
conclusion on traction, in a generalized sense, it is not an 
effective treatment for LBP patients. 
5. Conclusions 
Studies are more likely to have positive findings with 
high-quality studies compared to the studies with more 
methodological weaknesses. Although, some of the high-
quality studies have shown the positive level of certainty 
regarding VAX-D traction’s in the absence of effective 
treatment of LBP. Most of the available studies have 
methodological weaknesses with the potential for biased 
results. Only 1 of the 6 studies included has obtained the 
highest quality assessment and fulfilled all the biased 
outcome trials. Thus, the evidence presented in the studies 
was weak in several ways. First, there was weak evidence to 
show VAX-D was equivalent to conservative treatment 
approaches that have established evidence supporting their 
efficacy. Secondly, there was no evidence to show VAX-D is 
superior to conservative treatment options. Finally, there was 
no evidence to show the dosage requirement, patient position, 
and settings on the VAX-D table that led to the observed 
outcomes. Therefore, more studies concerning relevant 
technique in the treatment of chronic low back pain patients 
are warranted. 
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